Related references
Note: Only part of the references are listed.Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications
Sridevi Devaraj et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
Robert C. Axtell et al.
NATURE MEDICINE (2010)
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
M. Comabella et al.
BRAIN (2009)
Genome-wide pharmacogenomic analysis of the response to interferon β therapy in multiple sclerosis
Esther Byun et al.
ARCHIVES OF NEUROLOGY (2008)
Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis
Monica Marta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction
Qing-wu Yang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1
Huazhang An et al.
NATURE IMMUNOLOGY (2008)
'Fine tuning' TLR signaling
Luke A. J. O'Neill
NATURE IMMUNOLOGY (2008)
TAM receptors are pleiotropic inhibitors of the innate immune response
Carla V. Rothlin et al.
CELL (2007)
Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
J Río et al.
ANNALS OF NEUROLOGY (2006)
Toll-like receptors and innate immunity
Satoshi Uematsu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease
SM Kerfoot et al.
JOURNAL OF IMMUNOLOGY (2004)
Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon β:: Implications for clinical trials
J Río et al.
ANNALS OF NEUROLOGY (2002)
IRAK-M is a negative regulator of toll-like receptor signaling
K Kobayashi et al.
CELL (2002)
Roles of Toll-like receptors in innate immune responses
K Takeda et al.
GENES TO CELLS (2001)
Share Paper
